Upgrade to SI Premium - Free Trial

Passage Bio (PASG)

4.43 -0.07 (1.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26 *Est.)

Latest Headlines

Form SCHEDULE 13G/A Passage BIO, Inc. Filed by: Vestal Point Capital, LP August 14, 2026 4:09 PM - SEC Filing Form 10-Q Passage BIO, Inc. For: Jun 30 August 10, 2026 7:16 AM - SEC Filing Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc. July 22, 2026 6:04 AM - SEC Filing Form S-4 Passage BIO, Inc. July 21, 2026 5:23 PM - SEC Filing Form SCHEDULE 13D Passage BIO, Inc. Filed by: Lynx1 Capital Management LP July 2, 2026 9:20 PM - SEC Filing Form 4 Passage BIO, Inc. For: Jun 25 Filed by: Nichols Weston June 29, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G Passage BIO, Inc. Filed by: Baselake Partners, LP June 25, 2026 6:45 PM - SEC Filing Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc. June 24, 2026 5:11 PM - SEC Filing Form 425 Passage BIO, Inc. Filed by: Passage BIO, Inc. June 24, 2026 4:17 PM - SEC Filing Form 8-K Passage BIO, Inc. For: Jun 23 June 24, 2026 4:17 PM - SEC Filing Passage Bio and Remix Therapeutics agree to all-stock merger deal June 24, 2026 4:06 PM - StreetInsider Passage Bio and Remix Therapeutics Announce Merger Agreement June 24, 2026 4:05 PM - StreetInsider Guggenheim Downgrades Passage Bio Inc. (PASG) to Neutral June 10, 2026 6:47 AM - StreetInsider Full Article List